Literature DB >> 23224110

Total bilirubin is inversely associated with metabolic syndrome but not a risk factor for metabolic syndrome in Japanese men and women.

Eiji Oda1, Yoshifusa Aizawa.   

Abstract

Serum total bilirubin (TB) is a potent antioxidant and inversely associated with metabolic syndrome (MetS) in Asian populations. However, there has been no study which is aimed to investigate whether TB is a risk factor for MetS or not. We investigated cross-sectional and longitudinal associations between TB and MetS in 2,435 Japanese men and 1,436 Japanese women. The odds ratios [95 % confidence interval (CI)] of coexisting MetS for each 1 SD increase in log TB were 0.850 (0.754-0.958) (p = 0.008) in men and 0.809 (0.656-0.998) (p = 0.047) in women adjusted for sex, age, smoking, and other confounding covariates. Those for the third and fourth quartiles of TB compared with the lowest quartile were 0.720 (0.537-0.965) (p = 0.028) and 0.737 (0.530-1.052) (p = 0.095), respectively, in men and 0.822 (0.473-1.427) (p = 0.486) and 0.704 (0.362-1.369) (p = 0.301), respectively, in women. There was a tendency that TB and MetS changed inversely to each other. The similarly adjusted hazard ratios of developing MetS for each 1 SD increase in log TB and for the higher quartiles of TB compared with the lowest quartile were not significant either in men or in women. TB is inversely associated with MetS but not a risk factor for MetS in Japanese men and women.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23224110     DOI: 10.1007/s00592-012-0447-5

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  13 in total

1.  Atazanavir improves cardiometabolic measures but not vascular function in patients with long-standing type 1 diabetes mellitus.

Authors:  Jessica Milian; Allison B Goldfine; Jonah P Zuflacht; Caitlin Parmer; Joshua A Beckman
Journal:  Acta Diabetol       Date:  2015-01-08       Impact factor: 4.280

2.  Potential impact of the joint association of total bilirubin and gamma-glutamyltransferase with metabolic syndrome.

Authors:  Makoto Shiraishi; Muhei Tanaka; Hiroshi Okada; Yoshitaka Hashimoto; Shinichi Nakagawa; Muneaki Kumagai; Teruyuki Yamamoto; Hiromi Nishimura; Yohei Oda; Michiaki Fukui
Journal:  Diabetol Metab Syndr       Date:  2019-02-04       Impact factor: 3.320

3.  Serum bilirubin levels and risk of type 2 diabetes: results from two independent cohorts in middle-aged and elderly Chinese.

Authors:  Jing Wang; Yaru Li; Xu Han; Hua Hu; Fei Wang; Xiulou Li; Kun Yang; Jing Yuan; Ping Yao; Xiaoping Miao; Sheng Wei; Youjie Wang; Weihong Cheng; Yuan Liang; Xiaomin Zhang; Huan Guo; Handong Yang; Jianmin Yuan; Woon-Puay Koh; Frank B Hu; Tangchun Wu; An Pan; Meian He
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

4.  Direct Bilirubin Levels and Risk of Metabolic Syndrome in Healthy Chinese Men.

Authors:  Xiao-Hong Li; Hai-Yan Lin; Li-Ying Guan; Hui Peng; Meng-Meng Wen; Yong-Qian Cao; Xiu-Yun Jiang; Yi-Bing Wang
Journal:  Biomed Res Int       Date:  2017-12-20       Impact factor: 3.411

5.  Relationship between serum bilirubin levels and cardiovascular disease.

Authors:  Sunghwan Suh; Young Rak Cho; Mi Kyoung Park; Duk Kyu Kim; Nam H Cho; Moon-Kyu Lee
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

6.  Clinical sensitivity and specificity of serum total bilirubin - A study on thyroid status in clinically euthyroid non-obese, overweight, and obese type 2 diabetics.

Authors:  Rajendran Jayanthi; Abu Raghavan Srinivasan; Anandraj Lokesh Maran
Journal:  Int J Health Sci (Qassim)       Date:  2019 Jul-Aug

7.  Exposure to Zearalenone Leads to Metabolic Disruption and Changes in Circulating Adipokines Concentrations in Pigs.

Authors:  Veronika Nagl; Bertrand Grenier; Philippe Pinton; Ursula Ruczizka; Maximiliane Dippel; Moritz Bünger; Isabelle P Oswald; Laura Soler
Journal:  Toxins (Basel)       Date:  2021-11-08       Impact factor: 4.546

8.  The relationship of the anti-oxidant bilirubin with free thyroxine is modified by insulin resistance in euthyroid subjects.

Authors:  Petronella E Deetman; Stephan J L Bakker; Arjan J Kwakernaak; Gerjan Navis; Robin P F Dullaart
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

9.  Change in Serum Bilirubin Level as a Predictor of Incident Metabolic Syndrome.

Authors:  You-Bin Lee; Seung-Eun Lee; Ji Eun Jun; Jae Hwan Jee; Ji Cheol Bae; Sang-Man Jin; Jae Hyeon Kim
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

10.  Association of total bilirubin and indirect bilirubin content with metabolic syndrome among Kazakhs in Xinjiang.

Authors:  Hao Hao; Heng Guo; Ru-Lin Ma; Yi-Zhong Yan; Yun-Hua Hu; Jiao-Long Ma; Xiang-Hui Zhang; Xin-Ping Wang; Kui Wang; La-Ti Mu; Yan-Peng Song; Jing-Yu Zhang; Jia He; Shu-Xia Guo
Journal:  BMC Endocr Disord       Date:  2020-07-22       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.